background
streptococcu
equi
subspeci
equi
infect
elicit
protein
antibodi
titer
equid
interpret
titer
gener
accept
hypothesi
magnitud
equi
protein
sem
antibodi
titer
infect
titer
use
monitor
presenc
complic
risk
develop
complic
anim
fortyeight
hors
farm
involv
strangl
outbreak
method
clinic
observ
studi
equi
protein
antibodi
titer
measur
hors
week
infect
select
hors
week
infect
hors
categor
diseas
uncompl
case
persist
guttur
pouch
gp
infect
complic
case
metastat
abscess
purpura
hemorrhagica
secondari
infect
dysphagia
categori
compar
titer
result
twentyeight
develop
clinic
sign
equi
infect
uncompl
strangl
persist
gp
infect
complic
case
persist
gp
infect
complic
thirtythre
percent
hors
sem
antibodi
titer
eight
week
infect
hors
titer
evid
complic
complic
case
titer
outbreak
sensit
ci
confid
interv
sem
antibodi
titer
detect
complic
higher
specif
ci
conclus
clinic
import
outbreak
demonstr
sem
antibodi
titer
increas
infect
absenc
complic
strangl
tion
addit
object
follow
sem
antibodi
titer
month
infect
determin
immunoglobulin
decay
monitor
develop
addit
complic
hypothes
magnitud
sem
antibodi
titer
infect
sem
titer
use
monitor
presenc
complic
risk
develop
complic
hors
euthan
complic
case
includ
metastat
abscess
format
infarct
purpura
hemorrhagica
secondari
pleuropneumonia
dysphagia
report
outbreak
novel
high
proport
hors
sem
antibodi
titer
also
high
proport
hors
complic
diseas
compar
report
complic
rate
outbreak
case
fatal
complic
case
high
compar
report
case
fatal
complic
case
lastli
high
proport
hors
develop
persist
gp
infect
higher
previou
report
consist
recent
report
possibl
explan
higher
complic
rate
higher
convalesc
sem
antibodi
titer
includ
higher
dose
exposur
virul
equi
strain
lastli
hors
test
carrier
statu
presum
persist
gp
infect
howev
could
led
misclassif
initi
test
carrier
statu
hors
test
nasopharyng
lavag
larg
base
econom
howev
current
recommend
detect
carrier
statu
endoscopi
gp
lavag
limit
could
led
underestim
number
hors
persist
gp
infect
outbreak
could
also
led
overestim
sensit
specif
sem
antibodi
titer
detect
persist
gp
infect
hors
sem
antibodi
titer
howev
outbreak
studi
indic
sem
titer
use
manner
outbreak
illustr
util
sem
antibodi
titer
infect
equi
studi
demonstr
hors
may
complic
strangl
without
sem
antibodi
titer
hors
may
sem
antibodi
titer
without
complic
convalesc
sem
antibodi
titer
warrant
addit
investig
complic
persist
gp
infect
necessarili
confirm
hors
complic
diseas
result
studi
present
abstract
american
colleg
veterinari
intern
medicin
forum
seattl
wa
offlabel
antimicrobi
use
author
declar
human
ethic
approv
need
studi
http
